Doctors who perform in vitro fertilization typically rely on a visual assessment of the embryos when deciding which ones to transfer into the uterus, but two-thirds of such embryos fail to implant. A new test analyzes the proteins and small-molecule metabolites in the fluid surrounding each embryo and compares the resulting metabolic profile with that of a healthy embryo. The test improves implantation rates up to 30 percent. That means doctors can transfer fewer embryos, reducing the chances of an undesired multiple pregnancy.
Courtesy of Molecular Biometrics
Cost: $30,000 to $50,000 for the testing system in the U.S. market. (Tests will not add appreciably to the typical cost of $12,000 to $15,000 for an IVF treatment.)
Availability: Now in the U.K., Australia, Japan, Ireland, and Greece; seeking FDA approval in the U.S.
Company: Molecular Biometrics
Other products in this section:
Become an Insider to get the story behind the story — and before anyone else.
Gene therapy could free some people from a lifetime of blood transfusions
Correcting a genetic mutation lets beta thalassemia patients make healthy blood cells.
Pet cloning is bringing human cloning a little bit closer
People are copying pets to preserve a physical, and spiritual, connection to dead children.
When curing a disease with gene therapy is bad business
A drug giant turns over its pipeline of miracle drugs to a startup.